Table 5 Univariate analysis of 1-year survival condition after surgery in included individuals
Variations | Case (n = 160) | 1-year OS rate (%) | 3-year OS rate (%) | χ2 Value | P Value |
|---|---|---|---|---|---|
Sex | Â | Â | Â | 0.335 | 0.563 |
 Male | 89 | 66.3 | 25.4 |  |  |
 Female | 71 | 71.8 | 26.9 |  |  |
Age (hours) | Â | Â | Â | 0.070 | 0.792 |
  ≤ 60 | 60 | 71.7 | 19.5 |  |  |
  > 60 | 100 | 67.0 | 30.5 |  |  |
Diabetes | Â | Â | Â | 0.361 | 0.548 |
 Yes | 53 | 67.9 | 28.8 |  |  |
 No | 107 | 69.2 | 24.9 |  |  |
Jaundice reduction treatment before surgery | Â | Â | Â | 0.497 | 0.481 |
 Yes | 36 | 55.6 | 20.7 |  |  |
 No | 124 | 72.6 | 26.6 |  |  |
Preoperative total bilirubin (μmol/L) |  |  |  | 0.020 | 0.887 |
  ≤ 21 | 70 | 72.9 | 31.4 |  |  |
  > 21 | 90 | 65.6 | 26.0 |  |  |
Preoperative carbohydrate antigen 19–9 (U/ml) |  |  |  | 0.268 | 0.605 |
  ≤ 37 | 40 | 70.0 | 32.1 |  |  |
  > 37 | 120 | 68.3 | 22.4 |  |  |
Preoperative albumin (g/L) | Â | Â | Â | 2.255 | 0.133 |
  ≤ 40 | 119 | 67.2 | 23.5 |  |  |
  > 40 | 41 | 73.2 | 34.5 |  |  |
Postoperative 4Â weeks albumin (g/L) | Â | Â | Â | 2.031 | 0.154 |
  ≤ 40 | 124 | 66.1 | 23.8 |  |  |
  > 40 | 36 | 77.8 | 25.5 |  |  |
Pre-operative BMI | Â | Â | Â | 4.517 | 0.105 |
  < 18.5 | 11 | 81.8 | 42.4 |  |  |
 18.5–23.9 | 87 | 64.4 | 20.6 |  |  |
  ≥ 24.0 | 62 | 72.6 | 29.4 |  |  |
Postoperative 4Â weeks BMI | Â | Â | Â | 2.782 | 0.249 |
  < 18.5 | 13 | 69.2 | 32.3 |  |  |
 18.5–23.9 | 96 | 65.6 | 20.8 |  |  |
  ≥ 24.0 | 51 | 74.5 | 32.9 |  |  |
Preoperative LDL-c (mmol/L) | Â | Â | Â | 1.806 | 0.179 |
  ≤ 2.375 | 64 | 65.6 | 22.6 |  |  |
  > 2.375 | 96 | 70.8 | 28.5 |  |  |
Postoperative 3Â days LDL-c (mmol/L) | Â | Â | Â | 0.324 | 0.569 |
  ≤ 1.460 | 61 | 63.9 | 23.7 |  |  |
  > 1.460 | 99 | 71.7 | 26.5 |  |  |
Postoperative 1Â week LDL-c (mmol/L) | Â | Â | Â | 0.764 | 0.382 |
  ≤ 1.785 | 71 | 62.0 | 27.9 |  |  |
  > 1.785 | 89 | 74.2 | 24.8 |  |  |
Postoperative 4Â weeks LDL-c (mmol/L) | Â | Â | Â | 8.323 | 0.004 |
  ≤ 1.515 | 47 | 46.8 | 15.8 |  |  |
  > 1.515 | 113 | 77.9 | 30.4 |  |  |
Postoperative 8Â weeks LDL-c (mmol/L) | Â | Â | Â | 2.670 | 0.102 |
  ≤ 1.505 | 55 | 52.5 | 17.1 |  |  |
  > 1.505 | 105 | 72.5 | 21.6 |  |  |
Operation time (hours) | Â | Â | Â | 1.932 | 0.165 |
  ≤ 8 | 58 | 75.9 | 36.6 |  |  |
  > 8 | 102 | 64.9 | 20.8 |  |  |
Intraoperative hemorrhage volume (ml) | Â | Â | Â | 0.912 | 0.340 |
  ≤ 800 | 90 | 74.4 | 29.6 |  |  |
  > 800 | 70 | 61.4 | 21.6 |  |  |
Intraoperative transfusion | Â | Â | Â | 1.997 | 0.158 |
 Yes | 62 | 62.9 | 17.9 |  |  |
 No | 98 | 72.4 | 30.9 |  |  |
Tmour differentiation degree | Â | Â | Â | 14.154 | 0.000 |
 Low | 47 | 48.9 | 11.4 |  |  |
 Moderate/High | 113 | 77.0 | 32.4 |  |  |
Tumour size (cm) | Â | Â | Â | 7.028 | 0.008 |
  ≤ 4 | 112 | 72.0 | 32.6 |  |  |
  > 4 | 48 | 59.5 | 8.1 |  |  |
Lymphatic metastasis | Â | Â | Â | 14.425 | 0.000 |
 Yes | 100 | 62.0 | 17.6 |  |  |
 No | 60 | 80.0 | 40.3 |  |  |
Portal venous system invasion | Â | Â | Â | 3.255 | 0.071 |
 Yes | 70 | 61.4 | 20.7 |  |  |
 No | 90 | 74.4 | 30.4 |  |  |
Postoperative complications | Â | Â | Â | 0.230 | 0.631 |
 Yes | 48 | 64.6 | 27.1 |  |  |
 No | 112 | 70.5 | 25.5 |  |  |
Postoperative chemotherapy | Â | Â | Â | 0.173 | 0.677 |
 Yes | 86 | 75.6 | 22.4 |  |  |
 No | 74 | 60.8 | 31.3 |  |  |